For the Inventor, By the Inventor

Enter assignee name

Xspray Microparticles Ab

USPTO Granted Patents = 16

% Expired Patents = 12.5

EPO Patents = 2

Forward Citations = 465

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Mustafa Demirbüker (14 out of 22 patents)

Magnus Brisander (12 out of 23 patents)

Gérald Jesson (12 out of 20 patents)

4. Martin Malmsten (12 out of 20 patents)

5. Helene Dérand (12 out of 20 patents)

6. Thomas Meijer (1 out of 12 patents)

7. Victor Söderberg (1 out of 10 patents)

8. Mustafa Demirüker (1 out of 2 patents)

9. Per X Andersson (1 out of 40 patents)

10. Martin Malmsten (0 patent)

16 patents: Sort by Forward Citations

1. 10799459 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2020-10-13),

2. 10772877 - Pharmaceutical compositions (2020-09-15),

3. 10561645 - Pharmaceutical compositions (2020-02-18),

4. 10561644 - Pharmaceutical compositions (2020-02-18),

5. 10561643 - Pharmaceutical compositions (2020-02-18),

6. 10555937 - Pharmaceutical compositions (2020-02-11),

7. 10314830 - Pharmaceutical compositions (2019-06-11),

8. 10314829 - Pharmaceutical compositions (2019-06-11),

9. 10143683 - Pharmaceutical compositions (2018-12-04),

10. 9833443 - Pharmaceutical compositions (2017-12-05),

11. 9833442 - Pharmaceutical compositions (2017-12-05),

12. 9827230 - Pharmaceutical compositions (2017-11-28),

13. 9456992 - Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix forming component (2016-10-04),

14. 8585943 - Method and arrangement for the production of particles (2013-11-19),

15. 8585942 - Process and arrangement for producing particles utilizing subcritical fluids (2013-11-19),

Xspray Microparticles AB, based in Solna, Sweden, specializes in the development of innovative drug delivery systems utilizing its proprietary microparticle technology. The company focuses on enhancing the bioavailability and therapeutic efficacy of pharmaceutical compounds, particularly in the field of oncology. By leveraging advanced formulation techniques, Xspray aims to improve patient outcomes through more effective and targeted therapies, positioning itself as a key player in the pharmaceutical and biotechnology sectors.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#15 in Solna

#407 in Sweden

#37,788 in the World

Xspray Microparticles Ab

Forward Citations = 465

9 inventors:

Mustafa Demirbüker (14 out of 22 patents)

Magnus Brisander (12 out of 23 patents)

Gérald Jesson (12 out of 20 patents)

4. Martin Malmsten (12 out of 20 patents)

5. Helene Dérand (12 out of 20 patents)

Please report any incorrect information to [email protected]

Loading…